2-201246657-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000264275.9(CASP8):c.-27+12545A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.459 in 151,882 control chromosomes in the GnomAD database, including 16,748 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.46 ( 16748 hom., cov: 31)
Consequence
CASP8
ENST00000264275.9 intron
ENST00000264275.9 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.493
Publications
53 publications found
Genes affected
CASP8 (HGNC:1509): (caspase 8) This gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes composed of a prodomain, a large protease subunit, and a small protease subunit. Activation of caspases requires proteolytic processing at conserved internal aspartic residues to generate a heterodimeric enzyme consisting of the large and small subunits. This protein is involved in the programmed cell death induced by Fas and various apoptotic stimuli. The N-terminal FADD-like death effector domain of this protein suggests that it may interact with Fas-interacting protein FADD. This protein was detected in the insoluble fraction of the affected brain region from Huntington disease patients but not in those from normal controls, which implicated the role in neurodegenerative diseases. Many alternatively spliced transcript variants encoding different isoforms have been described, although not all variants have had their full-length sequences determined. [provided by RefSeq, Jul 2008]
CASP8 Gene-Disease associations (from GenCC):
- autoimmune lymphoproliferative syndrome type 2BInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.546 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CASP8 | NM_001228.5 | c.-27+12545A>G | intron_variant | Intron 2 of 9 | NP_001219.2 | |||
| CASP8 | NM_001400648.1 | c.-27+12545A>G | intron_variant | Intron 2 of 9 | NP_001387577.1 | |||
| CASP8 | NM_001400651.1 | c.-27+12545A>G | intron_variant | Intron 2 of 9 | NP_001387580.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CASP8 | ENST00000264275.9 | c.-27+12545A>G | intron_variant | Intron 2 of 9 | 1 | ENSP00000264275.5 | ||||
| CASP8 | ENST00000392258.7 | c.-27+12545A>G | intron_variant | Intron 2 of 7 | 1 | ENSP00000376087.3 | ||||
| CASP8 | ENST00000471383.5 | n.250+12545A>G | intron_variant | Intron 2 of 4 | 1 |
Frequencies
GnomAD3 genomes AF: 0.459 AC: 69625AN: 151764Hom.: 16734 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
69625
AN:
151764
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.459 AC: 69671AN: 151882Hom.: 16748 Cov.: 31 AF XY: 0.449 AC XY: 33339AN XY: 74234 show subpopulations
GnomAD4 genome
AF:
AC:
69671
AN:
151882
Hom.:
Cov.:
31
AF XY:
AC XY:
33339
AN XY:
74234
show subpopulations
African (AFR)
AF:
AC:
15203
AN:
41392
American (AMR)
AF:
AC:
6695
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
AC:
1355
AN:
3470
East Asian (EAS)
AF:
AC:
1060
AN:
5156
South Asian (SAS)
AF:
AC:
1287
AN:
4820
European-Finnish (FIN)
AF:
AC:
5199
AN:
10542
Middle Eastern (MID)
AF:
AC:
117
AN:
294
European-Non Finnish (NFE)
AF:
AC:
37412
AN:
67950
Other (OTH)
AF:
AC:
967
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1850
3700
5549
7399
9249
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
626
1252
1878
2504
3130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
864
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.